Effect of diphenylhydantoin on hypothalamic-pituitary-thyroid function in the rat

Area of Science:

• Endocrinology
• Pharmacology

Background:

• Chronic diphenylhydantoin (DPH) administration in rats lowers thyroxine (T4) and triiodothyronine (T3) without a TSH rise, suggesting DPH affects TSH secretion.
• Investigating DPH's direct impact on TSH secretion is crucial for understanding its endocrine effects.

Purpose of the Study:

• To investigate the direct effect of diphenylhydantoin (DPH) on thyroid-stimulating hormone (TSH) secretion.
• To explore the potential of DPH acting as a thyroid hormone agonist.

Main Methods:

• Administering DPH chronically and acutely to thyroidectomized, hypothyroid rats.
• Measuring serum TSH, pituitary TSH content, and TSH response to thyrotropin-releasing hormone (TRH).
• Assessing hypothalamic TRH content in treated and control groups.

Main Results:

• Chronic DPH administration decreased pituitary TSH content and TRH-stimulated TSH response in hypothyroid rats.
• Acute DPH administration increased hypothalamic TRH and pituitary TSH content, along with TRH-stimulated TSH response.
• These findings suggest DPH suppresses pituitary TSH secretion, potentially as a thyroid hormone agonist.

Conclusions:

• Diphenylhydantoin (DPH) suppresses pituitary TSH secretion, likely acting as a thyroid hormone agonist.
• The observed effects of DPH on TSH dynamics are dose- and time-dependent, similar to thyroid hormones.
• Further research is needed to fully elucidate the complex interaction between DPH and the hypothalamic-pituitary-thyroid axis.